|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.370 USD | 0.00% |
|
+1.72% | +31.67% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 2026-07-17 | 2026-07-20 | 2026-07-21 | 2026-07-22 | 2026-07-23 | |
|---|---|---|---|---|---|
| Last | US$2.380 | US$2.410 | US$2.360 | US$2.370 | US$2.370 |
| Volume | 549,893 | 643,857 | 519,945 | 276,755 | 448,972 |
| Change | +3.03% | +1.26% | -2.07% | +0.42% | 0.00% |
| Opening | US$2.270 | US$2.420 | US$2.420 | US$2.340 | US$2.340 |
| High | US$2.405 | US$2.450 | US$2.420 | US$2.390 | US$2.385 |
| Low | US$2.250 | US$2.380 | US$2.340 | US$2.310 | US$2.315 |
Performance
| 1 week | +1.72% | ||
| Current month | +1.72% | ||
| 1 month | +9.72% | ||
| 3 months | +7.73% | ||
| 6 months | +13.40% | ||
| Current year | +31.67% | ||
| 1 year | +50.00% | ||
| 3 years | +42.77% | ||
| 5 years | +41.92% | ||
| 10 years | -62.99% |
Volumes
marketsDaily volume
449,022
Estimated daily volume
449,022
Avg. Volume 20 sessions
567,086
Daily volume ratio
0.79
Avg. Volume 20 sessions USD
1,343,993.82
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
190,954,791
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.12 %
Free-Float capitalization (USD)
183,549,954
Average Daily Capital Traded
0.7%
Indicators
Moving average 5 days
2.366
Moving average 20 days
2.328
Moving average 50 days
2.145
Moving average 100 days
2.25
Price spread / (MMA5)
-0.17%
Price spread / (MMA20)
-1.75%
Price spread / (MMA50)
-9.48%
Price spread / (MMA100)
-5.06%
RSI 9 days
55.21
RSI 14 days
57.06
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +1.72% | +50.00% | +42.77% | 191M | |
| +1.97% | +2.53% | +52.73% | +156.66% | 1,037B | |
| +1.42% | +4.96% | +54.39% | +52.34% | 615B | |
| +1.43% | +5.25% | +37.31% | +78.74% | 448B | |
| +5.14% | +5.84% | +37.54% | +27.28% | 326B | |
| +1.85% | +4.64% | +38.53% | +39.87% | 293B | |
| -0.11% | +0.97% | +22.57% | +17.81% | 264B | |
| +0.25% | -3.10% | -24.44% | -42.25% | 216B | |
| +1.49% | +3.68% | +21.53% | +58.21% | 198B | |
| +0.40% | -0.64% | +18.78% | +62.28% | 162B | |
| Average | +0.86% | +1.18% | +30.89% | +49.37% | 355.76B | |
| Weighted average by Cap. | +0.66% | +1.47% | +38.33% | +75.23% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
81094338a8ce24f2ab4befede3c68c.HS90CRtpicS308XgA1rTH6FwKxAAJl2hTgv-gIy0bCE.VGM3Qiw-6o-B4pazUDaZTvVJeGdvFBT-fFmVzPTGAGJNYhtzblvRkNiFiA
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 2.370 | 21,606 | 393,256 |
| 15:59:58 | 2.375 | 244 | 371,650 |
| 15:59:56 | 2.375 | 200 | 371,406 |
| 15:59:56 | 2.370 | 200 | 371,206 |
| 15:59:56 | 2.370 | 800 | 371,006 |
| 15:59:56 | 2.370 | 400 | 370,206 |
| 15:59:56 | 2.370 | 200 | 369,806 |
| 15:59:56 | 2.370 | 400 | 369,606 |
| 15:59:56 | 2.370 | 100 | 369,206 |
| 15:59:56 | 2.370 | 200 | 369,106 |
Course Extremes
| 1 week | 2.25 |  | 2.45 |
| 1 month | 2.16 | | 2.48 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.41 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +31.67% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
